Aligning nanotoxicology with the 3Rs: What is needed to realise the short, medium and long-term opportunities?

[1]  Lang Tran,et al.  ITS-NANO - Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy , 2014, Particle and Fibre Toxicology.

[2]  Judith C. Madden,et al.  Development of computational models for the prediction of the toxicity of nanomaterials , 2018 .

[3]  Makoto Ohnishi,et al.  Lung carcinogenicity of inhaled multi-walled carbon nanotube in rats , 2015, Particle and Fibre Toxicology.

[4]  Robert Landsiedel,et al.  Genotoxicity of nanomaterials: Refining strategies and tests for hazard identification , 2013, Environmental and molecular mutagenesis.

[5]  Robert Landsiedel,et al.  Concern-driven integrated approaches for the grouping, testing and assessment of nanomaterials. , 2016, Environmental pollution.

[6]  Susan Wijnhoven,et al.  Approaches to the safety assessment of engineered nanomaterials (ENM) in food. , 2012, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  J. James,et al.  Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.

[8]  G. Ostojic,et al.  Carbon Nanotubes , 2010, Methods in Molecular Biology.

[9]  Fadri Gottschalk,et al.  Meeting the Needs for Released Nanomaterials Required for Further Testing-The SUN Approach. , 2016, Environmental science & technology.

[10]  Markus Schulz,et al.  No genotoxicity in rat blood cells upon 3- or 6-month inhalation exposure to CeO2 or BaSO4 nanomaterials , 2017, Mutagenesis.

[11]  Antonio Marcomini,et al.  Application of a quantitative weight of evidence approach for ranking and prioritising occupational exposure scenarios for titanium dioxide and carbon nanomaterials , 2014, Nanotoxicology.

[12]  Nikolaus A. Bornhöft,et al.  The Flows of Engineered Nanomaterials from Production, Use, and Disposal to the Environment , 2015 .

[13]  P. Couvreur,et al.  A relevant in vitro rat model for the evaluation of blood-brain barrier translocation of nanoparticles , 2005, Cellular and Molecular Life Sciences.

[14]  Craig A. Poland,et al.  Carbon nanotubes introduced into the abdominal cavity of mice show asbestos-like pathogenicity in a pilot study. , 2008, Nature nanotechnology.

[15]  Philip Demokritou,et al.  Preparation, characterization, and in vitro dosimetry of dispersed, engineered nanomaterials , 2017, Nature Protocols.

[16]  E. Cojocaru,et al.  Nanotechnology approaches for pain therapy through transdermal drug delivery. , 2015, Current pharmaceutical design.

[17]  Peter Wick,et al.  A comparative study of different in vitro lung cell culture systems to assess the most beneficial tool for screening the potential adverse effects of carbon nanotubes. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[18]  B. van Ravenzwaay,et al.  Inhalation toxicity of multiwall carbon nanotubes in rats exposed for 3 months. , 2009, Toxicological sciences : an official journal of the Society of Toxicology.

[19]  Andrew Worth,et al.  Applying quantitative structure-activity relationship approaches to nanotoxicology: current status and future potential. , 2013, Toxicology.

[20]  Dilpreet Singh,et al.  Thermal decomposition of nano-enabled thermoplastics: Possible environmental health and safety implications. , 2016, Journal of hazardous materials.

[21]  Vicki Stone,et al.  An in vitro study of the potential of carbon nanotubes and nanofibres to induce inflammatory mediators and frustrated phagocytosis , 2007 .

[22]  Craig A. Poland,et al.  Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma , 2010, Particle and Fibre Toxicology.

[23]  F. Nesslany,et al.  Lung inflammation and lack of genotoxicity in the comet and micronucleus assays of industrial multiwalled carbon nanotubes Graphistrength© C100 after a 90-day nose-only inhalation exposure of rats , 2015, Particle and Fibre Toxicology.

[24]  Peter Wick,et al.  Nanomaterial cell interactions: are current in vitro tests reliable? , 2011, Nanomedicine.

[25]  Peter Wick,et al.  Repeated exposure to carbon nanotube-based aerosols does not affect the functional properties of a 3D human epithelial airway model , 2015, Nanotoxicology.

[26]  Jo Anne Shatkin,et al.  Cellulose nanomaterials: life cycle risk assessment, and environmental health and safety roadmap , 2015 .

[27]  Mark R. Miller,et al.  Nanomaterials vs Ambient Ultrafine Particles: an Opportunity to Exchange Toxicology Knowledge. , 2016, Environmental health perspectives.

[28]  S. Doak,et al.  Automation and validation of micronucleus detection in the 3D EpiDerm™ human reconstructed skin assay and correlation with 2D dose responses , 2014, Mutagenesis.

[29]  Kristen K. Comfort,et al.  At the Crossroads of Nanotoxicology in vitro: Past Achievements and Current Challenges. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[30]  V. V. Kleandrova,et al.  Computational tool for risk assessment of nanomaterials: novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions. , 2014, Environmental science & technology.

[31]  M. Wiemann,et al.  In vitro and in vivo genotoxicity investigations of differently sized amorphous SiO2 nanomaterials. , 2015, Mutation research. Genetic toxicology and environmental mutagenesis.

[32]  Daniel C Leslie,et al.  A Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice , 2012, Science Translational Medicine.

[33]  W. Weber.  Protein binding. , 1972, Advances in biology of skin.

[34]  Rui Chen,et al.  Airborne engineered nanomaterials in the workplace-a review of release and worker exposure during nanomaterial production and handling processes. , 2017, Journal of hazardous materials.

[35]  Christian Mühlfeld,et al.  Particle and Fibre Toxicology Translocation of Particles and Inflammatory Responses after Exposure to Fine Particles and Nanoparticles in an Epithelial Airway Model , 2022 .

[36]  G. Oberdörster,et al.  Pulmonary retention of ultrafine and fine particles in rats. , 1992, American journal of respiratory cell and molecular biology.

[37]  S. Vranic,et al.  Development of an in vitro model of human bronchial epithelial barrier to study nanoparticle translocation. , 2015, Toxicology in vitro : an international journal published in association with BIBRA.

[38]  G. Jenkins,et al.  In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines , 2012, Mutation research.

[39]  G. Oberdörster,et al.  Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles , 2005, Environmental health perspectives.

[40]  Vincent Castranova,et al.  INHALATION EXPOSURE TO CARBON NANOTUBES (CNT) AND CARBON NANOFIBERS (CNF): METHODOLOGY AND DOSIMETRY , 2015, Journal of toxicology and environmental health. Part B, Critical reviews.

[41]  Thomas Hartung,et al.  Alternative in vitro assays in nanomaterial toxicology. , 2011, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[42]  K. Jensen,et al.  Feasibility and Challenges of Human Health Risk Assessment for Engineered Nanomaterials , 2016 .

[43]  Martin J. D. Clift,et al.  Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative , 2010, Archives of Toxicology.

[44]  J. Ferin,et al.  Increased pulmonary toxicity of ultrafine particles? II. Lung lavage studies , 1990 .

[45]  Jo Anne Shatkin,et al.  A multi-stakeholder perspective on the use of alternative test strategies for nanomaterial safety assessment. , 2013, ACS nano.

[46]  Olivier Jolliet,et al.  In vivo biodistribution and physiologically based pharmacokinetic modeling of inhaled fresh and aged cerium oxide nanoparticles in rats , 2016, Particle and Fibre Toxicology.

[47]  João Paulo Teixeira,et al.  Nanomaterials Versus Ambient Ultrafine Particles: An Opportunity to Exchange Toxicology Knowledge , 2017, Environmental health perspectives.

[48]  Jian Wang,et al.  Nano(Q)SAR: Challenges, pitfalls and perspectives , 2015, Nanotoxicology.

[49]  Helinor Johnston,et al.  Development of in vitro systems for nanotoxicology: methodological considerations , 2009, Critical reviews in toxicology.

[50]  Fiona Sewell,et al.  Testing Chemical Safety: What Is Needed to Ensure the Widespread Application of Non-animal Approaches? , 2015, PLoS biology.

[51]  Reinhard Kreiling,et al.  Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice. , 2016, Regulatory toxicology and pharmacology : RTP.

[52]  S. Kežić,et al.  Progress and future of in vitro models to study translocation of nanoparticles , 2015, Archives of Toxicology.

[53]  Antonio Marcomini,et al.  In vitro assessment of engineered nanomaterials using a hepatocyte cell line: cytotoxicity, pro-inflammatory cytokines and functional markers , 2012, Nanotoxicology.

[54]  Thomas Hartung,et al.  t⁴ workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterials. , 2011, ALTEX.

[55]  P. Morrow,et al.  Possible mechanisms to explain dust overloading of the lungs. , 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[56]  P. Baron,et al.  Unusual inflammatory and fibrogenic pulmonary responses to single-walled carbon nanotubes in mice. , 2005, American journal of physiology. Lung cellular and molecular physiology.

[57]  Olivier Jolliet,et al.  Toward a general physiologically-based pharmacokinetic model for intravenously injected nanoparticles , 2016, International journal of nanomedicine.

[58]  C. Domenici,et al.  In vitro toxicological screening of nanoparticles on primary human endothelial cells and the role of flow in modulating cell response , 2014, Nanotoxicology.

[59]  David Brown,et al.  Organ burden and pulmonary toxicity of nano-sized copper (II) oxide particles after short-term inhalation exposure , 2016, Nanotoxicology.

[60]  Robert Landsiedel,et al.  An in vitro alveolar macrophage assay for predicting the short-term inhalation toxicity of nanomaterials , 2016, Journal of Nanobiotechnology.

[61]  Andrew Williams,et al.  Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes , 2015, Particle and Fibre Toxicology.

[62]  M. Wiemann,et al.  Application of short-term inhalation studies to assess the inhalation toxicity of nanomaterials , 2014, Particle and Fibre Toxicology.

[63]  Yong Qian,et al.  Multi-walled carbon nanotube-induced gene expression in vitro: concordance with in vivo studies. , 2015, Toxicology.

[64]  Sangeeta Khare,et al.  Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology. , 2015, ALTEX.

[65]  F. Alessandrini,et al.  Toxicological effects of metal oxide nanomaterials , 2014 .

[66]  Reinhard Kreiling,et al.  A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping). , 2015, Regulatory toxicology and pharmacology : RTP.

[67]  W. Wohlleben,et al.  Eye irritation testing of nanomaterials using the EpiOcular™ eye irritation test and the bovine corneal opacity and permeability assay , 2015, Particle and Fibre Toxicology.

[68]  Lang Tran,et al.  A Multilaboratory Toxicological Assessment of a Panel of 10 Engineered Nanomaterials to Human Health—ENPRA Project—The Highlights, Limitations, and Current and Future Challenges , 2016, Journal of toxicology and environmental health. Part B, Critical reviews.

[69]  J. Collins,et al.  Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip , 2015, Proceedings of the National Academy of Sciences.

[70]  Hedwig M Braakhuis,et al.  Grouping nanomaterials to predict their potential to induce pulmonary inflammation. , 2016, Toxicology and applied pharmacology.

[71]  Meiying Wang,et al.  Use of a pro-fibrogenic mechanism-based predictive toxicological approach for tiered testing and decision analysis of carbonaceous nanomaterials. , 2015, ACS nano.

[72]  Hugh J. Byrne,et al.  Concern-driven integrated approaches to nanomaterial testing and assessment – report of the NanoSafety Cluster Working Group 10 , 2013, Nanotoxicology.

[73]  Anders Baun,et al.  A critical analysis of the environmental dossiers from the OECD sponsorship programme for the testing of manufactured nanomaterials , 2017 .

[74]  Judith Klein-Seetharaman,et al.  Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation. , 2010, Nature nanotechnology.

[75]  R L Binder,et al.  Xenobiotic metabolism gene expression in the EpiDermin vitro 3D human epidermis model compared to human skin. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[76]  Jeremy M. Gernand,et al.  Approaches to Develop Alternative Testing Strategies to Inform Human Health Risk Assessment of Nanomaterials , 2016, Risk analysis : an official publication of the Society for Risk Analysis.

[77]  David M. Brown,et al.  Exploring the cellular and tissue uptake of nanomaterials in a range of biological samples using multimodal nonlinear optical microscopy , 2015, Nanotechnology.

[78]  T. Hartung.  Toxicology for the twenty-first century , 2009, Nature.

[79]  Richard A. Brown,et al.  Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™) , 2016, Particle and Fibre Toxicology.

[80]  J. Heyder,et al.  Instillation of Six Different Ultrafine Carbon Particles Indicates a Surface Area Threshold Dose for Acute Lung Inflammation in Mice , 2005, Environmental health perspectives.

[81]  Feng Luan,et al.  Computational modeling in nanomedicine: prediction of multiple antibacterial profiles of nanoparticles using a quantitative structure-activity relationship perturbation model. , 2015, Nanomedicine.

[82]  Nicklas Raun Jacobsen,et al.  Comparative Hazard Identification by a Single Dose Lung Exposure of Zinc Oxide and Silver Nanomaterials in Mice , 2015, PloS one.

[83]  Jürgen Pauluhn,et al.  Subchronic 13-week inhalation exposure of rats to multiwalled carbon nanotubes: toxic effects are determined by density of agglomerate structures, not fibrillar structures. , 2010, Toxicological sciences : an official journal of the Society of Toxicology.

[84]  Jerzy Leszczynski,et al.  Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. , 2011, Nature nanotechnology.

[85]  Sumaira Ashraf,et al.  In vivo degeneration and the fate of inorganic nanoparticles. , 2016, Chemical Society reviews.

[86]  N. Zíková,et al.  Markers of lipid oxidative damage in the exhaled breath condensate of nano TiO2 production workers , 2017, Nanotoxicology.

[87]  Eric Fabian,et al.  A protocol to determine dermal absorption of xenobiotica through human skin in vitro , 2017, Archives of Toxicology.

[88]  Franz Oesch,et al.  Genotoxicity investigations on nanomaterials , 2012, Archives of Toxicology.

[89]  Lang Tran,et al.  Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges , 2013, Critical reviews in toxicology.

[90]  Usage of (eco)toxicological data for bridging data gaps between and grouping of nanoforms of the same substance , 2016 .

[91]  Robert Landsiedel,et al.  Toxico-/biokinetics of nanomaterials , 2012, Archives of Toxicology.

[92]  Kim Z Travis,et al.  Use of toxicokinetics to support chemical evaluation: Informing high dose selection and study interpretation. , 2012, Regulatory toxicology and pharmacology : RTP.

[93]  Jim E Riviere,et al.  A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles. , 2016, Nanomedicine.

[94]  Jürgen Schnekenburger,et al.  Pulmonary toxicity of nanomaterials: a critical comparison of published in vitro assays and in vivo inhalation or instillation studies. , 2014, Nanomedicine.

[95]  Oded Maimon,et al.  Predictive toxicology of cobalt nanoparticles and ions: comparative in vitro study of different cellular models using methods of knowledge discovery from data. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[96]  Natalie von Goetz,et al.  Translocation of gold nanoparticles across the lung epithelial tissue barrier: Combining in vitro and in silico methods to substitute in vivo experiments , 2015, Particle and Fibre Toxicology.

[97]  Kimberly M. Murdaugh,et al.  Bioavailability, distribution and clearance of tracheally-instilled and gavaged uncoated or silica-coated zinc oxide nanoparticles , 2014, Particle and Fibre Toxicology.

[98]  E. J. Foster,et al.  Fate of cellulose nanocrystal aerosols deposited on the lung cell surface in vitro. , 2015, Biomacromolecules.

[99]  Iseult Lynch,et al.  The evolution of the protein corona around nanoparticles: a test study. , 2011, ACS nano.

[100]  P. Borm,et al.  The quartz hazard: a variable entity. , 1998, The Annals of occupational hygiene.

[101]  Jim E Riviere,et al.  Protein binding modulates the cellular uptake of silver nanoparticles into human cells: implications for in vitro to in vivo extrapolations? , 2013, Toxicology letters.

[102]  Phil Sayre,et al.  Review of achievements of the OECD Working Party on Manufactured Nanomaterials' Testing and Assessment Programme. From exploratory testing to test guidelines. , 2016, Regulatory toxicology and pharmacology : RTP.